Integrated Soft Tissue Defect Reconstruction System

The integrated system combines a segmented skirted surgical mesh with AI, IoT, blockchain, and novel materials to revolutionize soft tissue defect reconstruction, providing real-time monitoring, personalized design, and decentralized data management.

The original segmented skirted surgical mesh patent addressed the need for a reliable and effective solution for soft tissue defect reconstruction. However, it lacked real-time monitoring capabilities, personalized design options, and secure data management. The new inventive concept solves these limitations by integrating the surgical mesh with cutting-edge technologies.

The integrated system comprises a segmented skirted surgical mesh, an AI-powered sensor for monitoring tissue healing and mesh integration, an IoT-enabled tracking device for real-time mesh performance tracking, and a blockchain-based patient data management system. The system enables personalized surgical mesh design using machine learning algorithms and 3D printing. Additionally, the mesh can be infused with novel antimicrobial materials for enhanced tissue integration. The decentralized blockchain network ensures secure and transparent data management.

The integration of AI, IoT, blockchain, and novel materials with the segmented skirted surgical mesh is new and non-obvious, providing a synergistic combination that revolutionizes soft tissue defect reconstruction. The use of machine learning algorithms for personalized design and decentralized blockchain networks for data management are particularly innovative.

Alternative embodiments include using different AI algorithms, IoT devices, or blockchain platforms. Variations of the system could include integrating additional sensors, using different materials for the mesh, or incorporating other technologies like robotics or virtual reality.

The integrated soft tissue defect reconstruction system has significant commercial potential in the medical device industry, particularly in the areas of hernia repair, tissue engineering, and personalized medicine. Target markets include hospitals, medical research institutions, and pharmaceutical companies.